Jubilant Pharmova Board Approves ₹800 Crore NCD Issuance and ₹2,500 Crore Borrowing Limit
Jubilant Pharmova Ltd · Outcome · 12 Oct 2026, 6:05 pm
Jubilant Pharmova Board Approves ₹800 Crore NCD Issuance and ₹2,500 Crore Borrowing Limit Jubilant Pharmova's board approved the private placement of up to 80,000 listed, rated, redeemable NCDs (face value ₹1,00,000 each) aggregating up to ₹800 crore across multiple tranches with a tenure of up to five years, to be listed on BSE. Additionally, the board is seeking shareholder approval via postal ballot to issue non-convertible debt securities on a private placement basis for an aggregate outstanding amount of up to ₹2,500 crore over a one-year period. Coupon rates will be determined via bidding.
Original exchange filing (PDF)
More announcements from Jubilant Pharmova Ltd
- Investor Meet Outcome · 16 Nov 2026
- Press Release · 14 Nov 2026
- Un-audited Financial Results for the Quarter and Half Year ended September 30, 2026 · 14 Nov 2026
- Outcome of Board Meeting · 14 Nov 2026
- Jubilant Pharmova Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Press Release · 11 Nov 2026
- Allotment · 06 Nov 2026
- Allotment of NCD · 06 Nov 2026
